Cargando…

P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE

Detalles Bibliográficos
Autores principales:	Wang, M., Mei, M., Barr, P. M., Barrientos, J., de Vos, S., Furman, R., Patel, K., Thompson, P. A., Choi, M., Kallam, A., Zhu, Y., Chakraborty, S., Marinello, P., Spurgeon, S. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429579/ http://dx.doi.org/10.1097/01.HS9.0000847788.96420.63

Ejemplares similares

P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE-001 STUDY
por: Spurgeon, Stephen, et al.
Publicado: (2023)

P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
por: Ozcan, Muhit, et al.
Publicado: (2023)

The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells
por: Liu, Dongli, et al.
Publicado: (2022)

P1435: PRECLINICAL EVALUATION OF ZILOVERTAMAB-BASED ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS IN NK AND T CELLS
por: Meinke, S., et al.
Publicado: (2022)

COLLABORATION AGREEMENT No. K1231
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005)

COLLABORATION FRAMEWORK AGREEMENT KN 2140 DG
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013)

ADDENDUM No.1TO COLLABORATION AGREEMENT KN2140/DG
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2014)

2140: Estimating microscopic structures of glomeruli in renal pathology
por: Sarder, Pinaki, et al.
Publicado: (2018)

Run 36, 15 GeV, 21.05-21.40
por: Keil, Eberhard
Publicado: (1971)

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS
por: Gkioka, Annita-Ioanna, et al.
Publicado: (2023)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Common variation at 10p12.31 near MLLT10 influences meningioma risk
por: Dobbins, Sara E, et al.
Publicado: (2011)

Emergency preparedness for mass gatherings: Lessons of “12.31” stampede in Shanghai Bund
por: Dong, Yong-He, et al.
Publicado: (2017)

A retrospective analysis of 1,231 patients with anemia after surgical treatment of hyperthyroidism
por: Tu, Ruisha, et al.
Publicado: (2018)

1231. Development of state public health goals for antimicrobial stewardship using local data
por: Biehle, Lauren, et al.
Publicado: (2023)

Brentuximab Vedotin
Publicado: (2012)

Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1
por: Nicolas, Guillaume G, et al.
Publicado: (2011)

1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
por: Pizzuto, Matteo Samuele, et al.
Publicado: (2020)

Single incision laparoscopic totally extraperitoneal hernioplasty: lessons learned from 1,231 procedures
por: Lee, Yoo Jung, et al.
Publicado: (2021)

Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015)

1231. Patient-Level Factors Associated with Vancomycin-Resistant Enterococci Transmission to Healthcare Workers Gowns or Gloves
por: Blanco, Natalia, et al.
Publicado: (2018)

SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism
por: Han, Jiangxue, et al.
Publicado: (2023)

Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure
por: Martínez-Arias, Laura, et al.
Publicado: (2023)

2140. Healthcare-Associated Infection Outbreak Investigation of an Elevation of Surgical Site Infections at a Critical Access Hospital
por: Pedati, Caitlin, et al.
Publicado: (2018)

2140. Utility of Respiratory Specimen Gram Stain for Predicting Final Culture Result in Patients with Clinically Diagnosed Pneumonia
por: Seadler, Jessica, et al.
Publicado: (2019)

Synchro Clock MkIV
por: Odier, P, et al.
Publicado: (2010)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

P1154: STUDY ZILO-301: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ZILOVERTAMAB PLUS IBRUTINIB VS IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
por: Yazji, S., et al.
Publicado: (2022)

1231. Microbial Profile of Biliary Stent, Bile and Surgical Site Cultures in Pancreaticoduodenectomy Patients – Implications for Surgical Prophylaxis
por: Hung, Kai Chee, et al.
Publicado: (2022)

Enfortumab Vedotin in urothelial cancer
por: Alt, Marie, et al.
Publicado: (2020)

Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022)

Drug extravasation with Enfortumab vedotin
por: Grant, Christopher Ryan, et al.
Publicado: (2023)

Erratum to ‘Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group’: [Annals of Oncology 30 (2019) 1221–1231]
por: Mandelker, D., et al.
Publicado: (2021)

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
por: Naing, Aung, et al.
Publicado: (2020)

Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study
por: Kinoshita, Tomohiro, et al.
Publicado: (2020)

A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
por: Fine, Howard, et al.
Publicado: (2023)

Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231
por: Liu, Bowei, et al.
Publicado: (2020)

Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer
por: Shang, Song, et al.
Publicado: (2019)

1231. Legionella Variability From Routine Environmental Testing Across All Veterans Health Administration (VHA) Medical Facilities
por: Jinadatha, Chetan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lonsqloq7u89la8aj7kbfpbdsh